Experiences with
Small cell lung cancer34,551 public posts
Early stage non-small cell, study request
Share your experience of early-stage non-small cell lung cancer
- Have you had surgery or radiotherapy for early-stage non-small cell lung cancer within the past year?
- Did you have you cancer treatment in England?
Want to take advantage of all our features? Just log in!
or
Join us! Small Cell Lung Cancer Living Room® Expert Speaker Event: "Small Cell Lung Cancer Treatment Landscape"
"Small Cell Lung Cancer Treatment Landscape"
Tuesday, March 18
The treatment landscape for small cell lung cancer (SCLC) is continually evolving, with ongoing research aimed at improving outcomes and finding more effective therapies.
FDA Approves Imfinzi (durvalumab) as First-Line Therapy for Limited-Stage SCLC
Read the full FDA announcement: https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-durvalumab-limited-stage-small-cell-lung-cancer
Share your experience of early-stage non-small cell lung cancer
Have you had surgery or radiotherapy for early-stage non-small cell lung cancer within the past year?
Did you have you cancer treatment in England?
Are you available to take part in a 1-hour interview online, by phone or in person?
Please join us next Tuesday, October 15th, for our Living Room discussion on Treating EGFR Mutated Non-Small Cell Lung Cancer
Join us for a conversation on how new targeted therapies and a greater understanding of tumor biology have advanced treatments for EGFR-mutated non-small cell lung cancer (NSCLC). First-generation targeted therapy drugs outperformed traditional chemotherapy, but new mutations led to resistance.
New approval for treatment of Small Cell Lung Cancer (SCLC)
Read the full FDA announcement here:https://go2.org/blog/fda-approves-imdelltra-tarlatamab-dlle-for-extensive-stage-small-cell-lung-cancer/